As of Jan 20
| +0.07 / +2.10%|
The 7 analysts offering 12-month price forecasts for Celldex Therapeutics Inc have a median target of 7.00, with a high estimate of 12.00 and a low estimate of 3.00. The median estimate represents a +105.28% increase from the last price of 3.41.
The current consensus among 7 polled investment analysts is to Hold stock in Celldex Therapeutics Inc. This rating has held steady since January, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.